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Background
The efficacy of universal screening and brief intervention
(SBI) for drug use among primary care (PC) patients is
unknown.
Methods
In this randomized trial (the Assessing Screening Plus
brief Intervention’s Resulting Efficacy to stop drug use
(ASPIRE) study) we tested the efficacy of a brief nego-
tiated interview (BNI), and an adaptation of motivational
interviewing (AMI), compared to no BI. Primary care
patient participants had Alcohol, Smoking and
Substance Involvement Screening Test (ASSIST) drug
specific scores of ≥4. Primary outcome at 6 months was
number of days use of the drug of most concern
(DOMC) in the past 30 days.
Results
Of 528 subjects, DOMC was: marijuana 63%, opioid 17%
(prescription opioid 11%), and cocaine 19%. ASSIST score
was ≥27 (consistent with dependence) for 18%, mean days
DOMC use (of 30 days) was 14.4. At 6 months, 98% com-
pleted follow-up and mean days DOMC use was 14.0.
Mean adjusted days use of the DOMC at 6 months (nega-
tive binomial regression) was 11.5 (no BI) vs. 11.2 (BNI)
(incidence rate ratio (IRR) 0.97, 95% CI 0.77-1.22) and
12.1 (AMI) (IRR 1.05, 95% CI 0.84-1.32) (p=0.81 for both
comparisons vs. no BI). There were also no significant
effects in analyses stratified by DOMC or ASSIST score.
Conclusions
In this trial, BNI and AMI did not have efficacy for
decreasing drug use. If other trials yield consistent results,
widespread implementation of drug screening and BI
should be reconsidered, and research should focus on
alternative ways to address drug use and consequences in
primary care settings. Funding was provided by the US
National Institutes of Health (National Institute on Drug
Abuse and National Center for Advancing Translational
Sciences).
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